You are here

drug pricing

Allergan CEO looks smart for pledging to rein in prices. But will it make a difference?

Stat/Pharmalot

Tue, 09/13/16 - 09:11 pm

Pharma suffers a setback in battle over Ohio drug pricing ballot measure

Stat/Pharmalot

Mon, 09/12/16 - 05:08 pm

Clinton spokeswoman defends drug plan after Pfizer comments

Yahoo/Reuters

Fri, 09/9/16 - 09:14 pm

Hillary Clinton

2016 Presidential election

Allergan's Social Contract: Protect Medical Innovation By Protecting Patients From Price Increases

LinkedIn

Fri, 09/9/16 - 10:27 am

Pfizer CEO says Clinton plan to curb drug prices would hurt consumers

Yahoo/Reuters

Thu, 09/8/16 - 06:41 pm

Hillary Clinton

Express Scripts targets inflammatory diseases for latest cost control program

Bizjournals.com

Thu, 09/8/16 - 09:52 am

Express Scripts

inflammatory disease

Can Allergan CEO Brent Saunders Lead Big Pharma To A Better Reputation?

Forbes

Wed, 09/7/16 - 10:02 am

Mylan faces two potential class action lawsuits over EpiPen pricing

Stat

Tue, 09/6/16 - 11:28 pm

Mylan may get the 'horns' from EpiPen competitors as pricing controversy burns hot

Fierce Pharma

Tue, 09/6/16 - 12:43 pm

Teva Pharmaceutical

Allergan CEO Brent Saunders takes a pricing pledge: Predatory practices must end

Endpoints

Tue, 09/6/16 - 09:55 am

Clinton seeks federal panel to determine if drug price hikes are justified

Stat

Fri, 09/2/16 - 09:40 am

Hillary Clinton

2016 Presidential election

The EpiPen Drama Shows What’s Wrong With How Drugs Are Priced

Bloomberg

Thu, 09/1/16 - 09:19 am

Mylan's branded ad spending on the EpiPen rose 357% — to $43 million in 2015 — over five years

Medical Marketing and Media

Wed, 08/31/16 - 09:04 pm

Express Scripts puts pricing cap on diabetes drugs

BioPharma Dive

Wed, 08/31/16 - 08:59 pm

Express Scripts

Lawmakers accuse Mylan of a ‘shell game’ in widening access to EpiPen

Stat

Wed, 08/31/16 - 09:25 am

Challengers eye a piece of EpiPen market as pricing scandal engulfs Mylan

Fierce Pharma

Tue, 08/30/16 - 10:02 am

Imprimis Pharmaceuticals

Gilead: Forbes Is Salty Over The Vermont Initiative

Seeking Alpha

Mon, 08/29/16 - 04:09 pm

Gilead Sciences

Pharma's reputation takes another hit with Mylan's Epipen pricing debacle

Fierce Pharma

Mon, 08/29/16 - 11:28 am

pharma industry

Innovators vs Exploiters: Drug Pricing And The Future Of Pharma

Forbes

Mon, 08/29/16 - 11:19 am

Mylan CEO Bresch hopes to tame the mob with a 50% discount for the EpiPen

Endpoints

Mon, 08/29/16 - 09:24 am

Pages